In the Original Investigation titled “Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112),”1 published November 2, 2021, in Table 3, footnote e was corrected to “R2 = 0.20 from the multivariable linear regression model” and footnote f was corrected to “R2 = 0.17 from the multiply imputed multivariable linear regression model.”
Reference
- 1.Fazeli S, Snyder BS, Gareen IF, et al. Patient-reported testing burden of breast magnetic resonance imaging among women with ductal carcinoma in situ: an ancillary study of the ECOG-ACRIN Cancer Research Group (E4112). JAMA Netw Open. 2021;4(11):e2129697. doi: 10.1001/jamanetworkopen.2021.29697 [DOI] [PMC free article] [PubMed] [Google Scholar]